GOLDMAN SACHS GROUP INC - SECOND SIGHT MED PRODS INC ownership

Back to all holdings Add to watchlist

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 47 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$60,000
+17.6%
29,364
-17.2%
0.00%–
Q1 2022$51,000
-7.3%
35,457
+4.4%
0.00%–
Q4 2021$55,000
-30.4%
33,950
+37.6%
0.00%–
Q3 2021$79,000
-27.5%
24,678
+87.6%
0.00%–
Q1 2021$109,000–13,152–0.00%–
 Download
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 181,169$259,0000.01%
CarsonAllaria Wealth Management, Ltd. 2,350$3,0000.00%
Engineers Gate Manager LP 15,428$22,0000.00%
Virtu Financial LLC 13,555$19,0000.00%
OSAIC HOLDINGS, INC. 1,602$3,0000.00%
FMR LLC 14$00.00%
US BANCORP \DE\ 2,000$3,0000.00%
WELLS FARGO & COMPANY/MN 1,682$2,0000.00%
NORTHERN TRUST CORP 42,000$60,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders